STAR CM (06698) issues a profit warning, expecting the mid-term net loss attributable to shareholders to expand to approximately 38 million to approximately 46 million yuan compared to the same period last year.
Starry Sky Chinese (06698) announced that the Group expects to achieve revenue of approximately RMB 43 million to RMB 47 million for the six months ending June 30, 2026 (compared to revenue of RMB 59 million for the same period in 2025) and a net loss attributable to the owners of the Company of approximately RMB 38 million to RMB 46 million for the six months ending June 30, 2026 (compared to a net loss of RMB 11 million for the same period in 2025).
STAR CM (06698) announced that the Group expects to achieve revenue ranging from approximately RMB 43 million to approximately RMB 47 million for the six months ending June 30, 2026 (compared to revenue of RMB 59 million for the same period in 2025) and an expected net loss attributable to the companys owners ranging from approximately RMB 38 million to approximately RMB 46 million for the six months ending June 30, 2026 (compared to a net loss attributable to the companys owners of RMB 11 million for the same period in 2025).
The anticipated increase in the net loss attributable to the companys owners for the six months ending June 30, 2026, is primarily due to the following reasons: the number of variety shows acquired by the Group has decreased compared to the same period last year, resulting in a reduction in the gross profit generated from the production of variety shows; and the fair value of financial assets measured at fair value through profit or loss that the Group has acquired has decreased, primarily due to fluctuations in the stock prices of the listed companies in which the company has invested.
Related Articles

PICC P&C (02328): Lu Chen's qualifications for the position of Executive Director have been approved.

MILLIONHOPE IND(01897) spent HKD 49,500 to repurchase 100,000 shares on August 6.

TRANSTHERA-B(02617): Jientai (Tian Geketin Tablets) has been approved for marketing by the National Medical Products Administration.
PICC P&C (02328): Lu Chen's qualifications for the position of Executive Director have been approved.

MILLIONHOPE IND(01897) spent HKD 49,500 to repurchase 100,000 shares on August 6.

TRANSTHERA-B(02617): Jientai (Tian Geketin Tablets) has been approved for marketing by the National Medical Products Administration.

RECOMMEND





